Wu CT - Search Results

1

[Intralymphatic chemotherapy with adriamycin-adsorbing nanometric activated carbon:pharmacokinetic experiment with dogs].

Hua ZH, Cai SY, Huang GJ, Wu CT, Gan J, Hu CE, Ni QX, Zhang YL. Hua ZH, et al. Among authors: wu ct. Zhonghua Yi Xue Za Zhi. 2008 Aug 19;88(32):2299-301. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19087684 Chinese.

2

Application of "papillary-like main pancreatic duct invaginated" pancreaticojejunostomy for normal soft pancreas cases.

Zhang B, Xu J, Liu C, Long J, Liu L, Xu Y, Wu C, Luo G, Ni Q, Li M, Yu X. Zhang B, et al. Sci Rep. 2013;3:2068. doi: 10.1038/srep02068. Sci Rep. 2013. PMID: 23797701 Free PMC article.

3

Ligamentum teres hepatis patch enhances the healing of pancreatic fistula after distal pancreatectomy.

Wu CT, Xu WY, Liu L, Long J, Xu J, Ni QX, Liu C, Yu XJ. Wu CT, et al. Hepatobiliary Pancreat Dis Int. 2013 Dec;12(6):651-5. doi: 10.1016/s1499-3872(13)60102-2. Hepatobiliary Pancreat Dis Int. 2013. PMID: 24322752

4

Molecular mechanism underlying lymphatic metastasis in pancreatic cancer.

Xiao Z, Luo G, Liu C, Wu C, Liu L, Liu Z, Ni Q, Long J, Yu X. Xiao Z, et al. Biomed Res Int. 2014;2014:925845. doi: 10.1155/2014/925845. Epub 2014 Jan 22. Biomed Res Int. 2014. PMID: 24587996 Free PMC article. Review.

5

The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib.

Wang WQ, Liu L, Xu HX, Sun HC, Wu CT, Zhu XD, Zhang W, Xu J, Liu C, Long J, Ni QX, Tang ZY, Yu XJ. Wang WQ, et al. Among authors: wu ct. Oncotarget. 2014 Jun 15;5(11):3895-906. doi: 10.18632/oncotarget.2019. Oncotarget. 2014. PMID: 25008315 Free PMC article.

6

A preoperative serum signature of CEA+/CA125+/CA19-9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer.

Liu L, Xu H, Wang W, Wu C, Chen Y, Yang J, Cen P, Xu J, Liu C, Long J, Guha S, Fu D, Ni Q, Jatoi A, Chari S, McCleary-Wheeler AL, Fernandez-Zapico ME, Li M, Yu X. Liu L, et al. Int J Cancer. 2015 May 1;136(9):2216-27. doi: 10.1002/ijc.29242. Epub 2014 Oct 18. Int J Cancer. 2015. PMID: 25273947

7

Metabolic tumor burden: a new promising way to reach precise personalized therapy in PDAC.

Xiang J, Liu L, Wang W, Xu H, Wu C, Xu J, Liu C, Long J, Ni Q, Yu X. Xiang J, et al. Cancer Lett. 2015 Apr 10;359(2):165-8. doi: 10.1016/j.canlet.2015.01.023. Epub 2015 Jan 21. Cancer Lett. 2015. PMID: 25617800 Review.

8

Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden.

Liu L, Xu HX, Wang WQ, Wu CT, Xiang JF, Liu C, Long J, Xu J, Fu de L, Ni QX, Houchen CW, Postier RG, Li M, Yu XJ. Liu L, et al. Among authors: wu ct. Oncotarget. 2016 Feb 2;7(5):5943-56. doi: 10.18632/oncotarget.6819. Oncotarget. 2016. PMID: 26745601 Free PMC article.

9

Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL.

Xiang JF, Wang WQ, Liu L, Xu HX, Wu CT, Yang JX, Qi ZH, Wang YQ, Xu J, Liu C, Long J, Ni QX, Li M, Yu XJ. Xiang JF, et al. Among authors: wu ct. Sci Rep. 2016 Jan 12;6:19222. doi: 10.1038/srep19222. Sci Rep. 2016. Retraction in: Sci Rep. 2016 May 13;6:25115. doi: 10.1038/srep25115. PMID: 26753987 Free PMC article. Retracted.

10

ALDOA functions as an oncogene in the highly metastatic pancreatic cancer.

Ji S, Zhang B, Liu J, Qin Y, Liang C, Shi S, Jin K, Liang D, Xu W, Xu H, Wang W, Wu C, Liu L, Liu C, Xu J, Ni Q, Yu X. Ji S, et al. Cancer Lett. 2016 Apr 28;374(1):127-135. doi: 10.1016/j.canlet.2016.01.054. Epub 2016 Feb 12. Cancer Lett. 2016. PMID: 26854714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,270 results

Search Page